| pubmed-article:6087954 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6087954 | lifeskim:mentions | umls-concept:C0330390 | lld:lifeskim |
| pubmed-article:6087954 | lifeskim:mentions | umls-concept:C0027061 | lld:lifeskim |
| pubmed-article:6087954 | lifeskim:mentions | umls-concept:C0007412 | lld:lifeskim |
| pubmed-article:6087954 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
| pubmed-article:6087954 | lifeskim:mentions | umls-concept:C0441472 | lld:lifeskim |
| pubmed-article:6087954 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:6087954 | pubmed:dateCreated | 1984-10-12 | lld:pubmed |
| pubmed-article:6087954 | pubmed:abstractText | Experiments on an isolated rat heart were made to compare the damaging action on the myocardium of catecholamines (noradrenaline, adrenaline and isoproterenol) differing in the affinity for beta-receptors. The damage to myocardial cells was evaluated from the release into the perfusate of intracellular enzymes (creatine phosphokinase and lactate dehydrogenase) and the number of contracture damaged myocytes. Noradrenaline exerted the most powerful damaging action on the myocardium at a concentration of 10(-6) M. Perfusion of the heart with isoproterenol at concentrations of 10(-6) M and 10(-5) M did not lead to the affection of cardiomyocytes. It was isoproterenol concentration exceeding noradrenaline concentration 100 times that produced an increase in the rate of the release of the enzymes to the perfusate and a rise of the number of contractures in the myocardium, with the above increase being less than that provoked by adrenaline and noradrenaline (10(-6) M). It is concluded that the mechanism of the cardiotoxic effect of catecholamines cannot be reduced only to their effect on myocardial beta-receptors. | lld:pubmed |
| pubmed-article:6087954 | pubmed:language | rus | lld:pubmed |
| pubmed-article:6087954 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6087954 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6087954 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6087954 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6087954 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6087954 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6087954 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6087954 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6087954 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:6087954 | pubmed:issn | 0365-9615 | lld:pubmed |
| pubmed-article:6087954 | pubmed:author | pubmed-author:SerovR ARA | lld:pubmed |
| pubmed-article:6087954 | pubmed:author | pubmed-author:SapryginD BDB | lld:pubmed |
| pubmed-article:6087954 | pubmed:author | pubmed-author:KashtélianL... | lld:pubmed |
| pubmed-article:6087954 | pubmed:author | pubmed-author:SmotrovS PSP | lld:pubmed |
| pubmed-article:6087954 | pubmed:author | pubmed-author:AshirovP MPM | lld:pubmed |
| pubmed-article:6087954 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6087954 | pubmed:volume | 98 | lld:pubmed |
| pubmed-article:6087954 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6087954 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6087954 | pubmed:pagination | 175-7 | lld:pubmed |
| pubmed-article:6087954 | pubmed:dateRevised | 2008-10-8 | lld:pubmed |
| pubmed-article:6087954 | pubmed:meshHeading | pubmed-meshheading:6087954-... | lld:pubmed |
| pubmed-article:6087954 | pubmed:meshHeading | pubmed-meshheading:6087954-... | lld:pubmed |
| pubmed-article:6087954 | pubmed:meshHeading | pubmed-meshheading:6087954-... | lld:pubmed |
| pubmed-article:6087954 | pubmed:meshHeading | pubmed-meshheading:6087954-... | lld:pubmed |
| pubmed-article:6087954 | pubmed:meshHeading | pubmed-meshheading:6087954-... | lld:pubmed |
| pubmed-article:6087954 | pubmed:meshHeading | pubmed-meshheading:6087954-... | lld:pubmed |
| pubmed-article:6087954 | pubmed:meshHeading | pubmed-meshheading:6087954-... | lld:pubmed |
| pubmed-article:6087954 | pubmed:meshHeading | pubmed-meshheading:6087954-... | lld:pubmed |
| pubmed-article:6087954 | pubmed:meshHeading | pubmed-meshheading:6087954-... | lld:pubmed |
| pubmed-article:6087954 | pubmed:meshHeading | pubmed-meshheading:6087954-... | lld:pubmed |
| pubmed-article:6087954 | pubmed:meshHeading | pubmed-meshheading:6087954-... | lld:pubmed |
| pubmed-article:6087954 | pubmed:meshHeading | pubmed-meshheading:6087954-... | lld:pubmed |
| pubmed-article:6087954 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6087954 | pubmed:articleTitle | [Is the damaging action of catecholamines on the myocardium realized via hyperstimulation of the beta receptors?]. | lld:pubmed |
| pubmed-article:6087954 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6087954 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:6087954 | pubmed:publicationType | In Vitro | lld:pubmed |
| pubmed-article:6087954 | pubmed:publicationType | English Abstract | lld:pubmed |
